A Safety Study on Honghua Injection Based on Literature
10.3969/j.issn.1005-5304.2014.11.012
- VernacularTitle:基于文献的红花注射液安全性研究
- Author:
Lei BIE
;
Naijun CHAI
;
Cheng CHANG
;
Jinhui TIAN
;
Jing GU
;
Xiaogang WANG
- Publication Type:Journal Article
- Keywords:
Honghua Injection;
system evaluation;
adverse reactions;
cardiovascular drug;
traditional Chinese medicine injection
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2014;(11):37-41
- CountryChina
- Language:Chinese
-
Abstract:
Objective To conduct a comprehensive evaluation on safety of Honghua Injection through adopting the method of the evidence-based method;To provide reference for clinical reasonable application of Honghua Injection. Methods Computers were used to retrieve some Chinese databases, such as China Biology Medicine, China National Knowledge Infrastructure, Wangfang Database and VIP database. At the same time, other search methods were employed, up to July 2013, including all research types about Honghua Injection. The adverse reactions in the reports of published literature were analyzed by description and statistical analysis. Results Sixty-nine researches on Honghua Injection were included. The total cases of adverse drug reaction (ADR) were 1111, among which male cases were 568 (51%), and female cases were 543 (49%). Thirty-six (52%) papers described ADR of Honghua Injection in detail, and thirty-three (48%) papers just mentioned ADR or did not describe ADR in detail. Skin, skin accessories damage and pathological changes in circulatory system were main contents of ADR. In terms of original diseases, diseases of circulatory system play an important role. Solvent medium was largely in line with its product specification requirements. Most ADR appeared when the drug was used for the first time, from 5 minutes to 5 days. Conclusion The current published literature data show that severe ADR does not happen after the intervention of Honghua Injection.
